Is ATBPF or HDV a better dividend investment in 2026?

ATBPF currently yields 927.64% with a 5% 5-year dividend growth rate. HDV yields 2.92% with 4.8% growth. The better choice depends on your goal: ATBPF offers higher current income.

What is the dividend yield difference between ATBPF and HDV?

ATBPF has a forward dividend yield of 927.64% ($2.00/share annually). HDV yields 2.92% ($3.96/share annually). The yield gap is 924.72 percentage points.

Home › Compare › ATBPF vs HDV

ATBPF vs HDV: Dividend Comparison 2026

ATBPF yields 927.64% · HDV yields 2.92%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ATBPF wins by $9822464.74M in total portfolio value

INVESTMENT

TIME HORIZON10 years

ATBPF

● Live price

927.64%

Share price

$0.22

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$9822464.76M

Annual income

$8,103,949,924,179.18

Full ATBPF calculator →

HDV

iShares Core High Dividend ETF

● Live price

2.92%

Share price

$135.39

Annual div

$3.96

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$24.3K

Annual income

$352.73

Full HDV calculator →

Portfolio growth — ATBPF vs HDV

📍 ATBPF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	ATBPF	HDV
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, ATBPF + HDV cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

ATBPF pays

HDV pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ATBPF

Annual income on $10K today (after 15% tax)

$78,849.72/yr

After 10yr DRIP, annual income (after tax)

$6,888,357,435,552.30/yr

HDV

Annual income on $10K today (after 15% tax)

$248.52/yr

After 10yr DRIP, annual income (after tax)

$299.82/yr

At 15% tax rate, ATBPF beats the other by $6,888,357,435,252.48/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ATBPF + HDV for your $10,000?

ATBPF: 50%HDV: 50%

100% HDV50/50100% ATBPF

Portfolio after 10yr

$4911232.39M

Annual income

$4,051,974,962,265.95/yr

Blended yield

82.50%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ATBPF buys

HDV buys

No recent congressional trades found for ATBPF or HDV in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricATBPFHDV

Forward yield	927.64% ✓	2.92%
Annual dividend / share	$2.00	$3.96 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$9822464.76M ✓	$24.3K
Annual income after 10y	$8,103,949,924,179.18 ✓	$352.73
Total dividends collected	$9689719.06M ✓	$3.2K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: ATBPF vs HDV ($10,000, DRIP)

Year	ATBPF Portfolio	ATBPF Income/yr	HDV Portfolio	HDV Income/yr	Gap
1← crossover	$103,464	$92,764.38	$11,002	$292.38	+$92.5K → ATBPF
2	$1,007,698	$896,991.47	$12,084	$300.36	+$995.6K → ATBPF
3	$9,243,012	$8,164,775.26	$13,250	$308.02	+$9.23M → ATBPF
4	$79,881,224	$69,991,201.10	$14,506	$315.35	+$79.87M → ATBPF
5	$650,788,343	$565,315,433.07	$15,858	$322.35	+$650.77M → ATBPF
6	$5,000,639,395	$4,304,295,867.45	$17,313	$329.04	+$5000.62M → ATBPF
7	$36,261,047,555	$30,910,363,402.53	$18,878	$335.42	+$36261.03M → ATBPF
8	$248,275,740,228	$209,476,419,343.92	$20,560	$341.49	+$248275.72M → ATBPF
9	$1,606,088,634,392	$1,340,433,592,348.06	$22,367	$347.25	+$1606088.61M → ATBPF
10	$9,822,464,762,978	$8,103,949,924,179.18	$24,307	$352.73	+$9822464.74M → ATBPF

ATBPF vs HDV: Complete Analysis 2026

ATBPF — Stock

Antibe Therapeutics Inc., a biotechnology company, engages in developing novel therapeutics and medical devices in the areas of pain, inflammation and regenerative medicine in Canada, Europe, the United States, and internationally. The company's drugs are designed to prevent the gastrointestinal damage and bleeding caused by non-steroidal anti-inflammatory drugs. Its lead compound is Otenaproxesul, a hydrogen sulfide-releasing derivative of naproxen for treating post-operative pain, migraine, dysmenorrhea, traumatic injury, dental pain, and gout that has completed Phase 2B gastrointestinal safety study. In addition, the company's products comprise ATB-352, which is in preclinical stage for acute pain. Antibe Therapeutics Inc. was incorporated in 2009 and is headquartered in Toronto, Canada.

Full ATBPF Calculator →

HDV — ETF

The iShares Core High Dividend ETF seeks to track the investment results of an index composed of relatively high dividend paying U.S. equities.

Full HDV Calculator →

📬

Get this ATBPF vs HDV comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ATBPF vs SCHD ATBPF vs JEPI ATBPF vs O ATBPF vs KO ATBPF vs MAIN ATBPF vs VYM ATBPF vs DVY ATBPF vs SPHD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.